Federal contract award
75A50322F80030
DOXYCYCLINE HYCLATE TABLETS AND AMOXICILLIN TRIHYDRATE CAPSULES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ASPR/ORM-SNS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79720D0198 |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $99.0M |
| Current contract value | $99.0M |
| Potential contract value / ceiling | $99.0M |
| Start date | Sep 30, 2022 |
| Current end date | Mar 23, 2026 |
| Potential end date | Mar 23, 2026 |
| Latest award activity | Mar 24, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 24, 2026 | P00007 | $-40.6M | THE PURPOSE OF THIS MODIFICATION IS TO DESCOPE AMOXICILLIN TRIHYDRATE 500 MG CLINS. |
| Feb 20, 2026 | P00006 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND AMOXICILLIN TRIHYDRATE 500 MG CLINS |
| Jan 30, 2026 | P00005 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND AMOXICILLIN TRIHYDRATE 500 MG CLINS |
| Dec 29, 2025 | P00004 | $0 | THE PURPOSE OF THIS MODIFICATION IS FOR AMOXICILLIN TRIHYDRATE 500 MG CLINS |
| Jun 27, 2025 | P00003 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A NO COST EXTENSION TO EXTEND THE PERIOD OF PERFORMANCE. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.